Literature DB >> 22625994

Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity.

Masayuki Kikumori1, Ryo C Yanagita, Harukuni Tokuda, Nobutaka Suzuki, Hiroshi Nagai, Kiyotake Suenaga, Kazuhiro Irie.   

Abstract

Aplog-1, a simplified analogue of tumor-promoting debromoaplysiatoxin, is antiproliferative but not tumor-promoting. Our recent study has suggested that local hydrophobicity around the spiroketal moiety is a crucial determinant for antiproliferative activity. To further clarify the structural features relevant to the activity, we synthesized two methyl derivatives of aplog-1, where a methyl group was installed at position 4 or 10 of the spiroketal moiety. 10-Methyl-aplog-1 (5) bound to the C1B domains of novel PKCs (δ, η, and θ) with subnanomolar K(i) values, approximately 10-20 times stronger than aplog-1, and markedly inhibited the growth of many human cancer cell lines, while 4-methyl-aplog-1 (4) had levels of activity similar to those of aplog-1. Interestingly, 5 showed little tumor-promoting activity unlike the tumor promoter debromoaplysiatoxin. These results suggest that 5 is a potent PKC ligand without tumor-promoting activity and could be a therapeutic lead for the treatment of cancer, like bryostatins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22625994     DOI: 10.1021/jm300566h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Function through synthesis-informed design.

Authors:  Paul A Wender; Ryan V Quiroz; Matthew C Stevens
Journal:  Acc Chem Res       Date:  2015-03-05       Impact factor: 22.384

2.  Anti-Chikungunya viral activities of aplysiatoxin-related compounds from the marine cyanobacterium Trichodesmium erythraeum.

Authors:  Deepak Kumar Gupta; Parveen Kaur; See Ting Leong; Lik Tong Tan; Michèle R Prinsep; Justin Jang Hann Chu
Journal:  Mar Drugs       Date:  2014-01-03       Impact factor: 5.118

3.  Co-ordinated activation of classical and novel PKC isoforms is required for PMA-induced mTORC1 activation.

Authors:  Mengling Liu; Christopher J Clarke; Mohamed F Salama; Yeon Ja Choi; Lina M Obeid; Yusuf A Hannun
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

4.  Loss of the Phenolic Hydroxyl Group and Aromaticity from the Side Chain of Anti-Proliferative 10-Methyl-aplog-1, a Simplified Analog of Aplysiatoxin, Enhances Its Tumor-Promoting and Proinflammatory Activities.

Authors:  Yusuke Hanaki; Masayuki Kikumori; Harukuni Tokuda; Mutsumi Okamura; Shingo Dan; Naoko Adachi; Naoaki Saito; Ryo C Yanagita; Kazuhiro Irie
Journal:  Molecules       Date:  2017-04-13       Impact factor: 4.411

5.  Two New Neo-debromoaplysiatoxins-A Pair of Stereoisomers Exhibiting Potent Kv1.5 Ion Channel Inhibition Activities.

Authors:  Ting-Ting Fan; Hui-Hui Zhang; Yang-Hua Tang; Fan-Zhong Zhang; Bing-Nan Han
Journal:  Mar Drugs       Date:  2019-11-21       Impact factor: 5.118

6.  Chemical and Biological Study of Novel Aplysiatoxin Derivatives from the Marine Cyanobacterium Lyngbya sp.

Authors:  Hui-Hui Zhang; Xin-Kai Zhang; Ran-Ran Si; Si-Cheng Shen; Ting-Ting Liang; Ting-Ting Fan; Wei Chen; Lian-Hua Xu; Bing-Nan Han
Journal:  Toxins (Basel)       Date:  2020-11-23       Impact factor: 4.546

7.  Chemical and biological study of aplysiatoxin derivatives showing inhibition of potassium channel Kv1.5.

Authors:  Yang-Hua Tang; Jing Wu; Ting-Ting Fan; Hui-Hui Zhang; Xiao-Xia Gong; Zheng-Yu Cao; Jian Zhang; Hou-Wen Lin; Bing-Nan Han
Journal:  RSC Adv       Date:  2019-03-06       Impact factor: 4.036

8.  A new lyngbyatoxin from the Hawaiian cyanobacterium Moorea producens.

Authors:  Weina Jiang; Wei Zhou; Hajime Uchida; Masayuki Kikumori; Kazuhiro Irie; Ryuichi Watanabe; Toshiyuki Suzuki; Bryan Sakamoto; Michiya Kamio; Hiroshi Nagai
Journal:  Mar Drugs       Date:  2014-05-12       Impact factor: 5.118

9.  The Novel PKC Activator 10-Methyl-Aplog-1 Combined with JQ1 Induced Strong and Synergistic HIV Reactivation with Tolerable Global T Cell Activation.

Authors:  Ayaka Washizaki; Megumi Murata; Yohei Seki; Masayuki Kikumori; Yinpui Tang; Weikeat Tan; Nadita P Wardani; Kazuhiro Irie; Hirofumi Akari
Journal:  Viruses       Date:  2021-10-09       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.